Autoimmune polyendocrine syndrome type 2
Autoimmune Polyendocrine Syndrome Type 2 (APS-2), also known as Schmidt's syndrome, is a complex autoimmune disorder characterized by the coexistence of at least two autoimmune diseases, including Addison's disease, thyroid autoimmune diseases (such as Graves' disease or Hashimoto's thyroiditis), and type 1 diabetes mellitus. This syndrome is more common in females and typically presents in adulthood.
Etiology and Pathogenesis[edit | edit source]
The exact cause of APS-2 is unknown, but it is believed to involve a combination of genetic predisposition and environmental factors. The HLA-DQ gene is often associated with the syndrome, suggesting a strong genetic component. Environmental triggers may include viral infections, stress, and other unknown factors that initiate an autoimmune response in genetically susceptible individuals.
Clinical Manifestations[edit | edit source]
APS-2 presents with a variety of symptoms depending on the specific autoimmune diseases involved. Common manifestations include:
- Addison's disease symptoms: fatigue, weight loss, skin hyperpigmentation, low blood pressure, and salt craving.
- Thyroid autoimmune diseases symptoms: depending on whether the patient has Graves' disease (hyperthyroidism) or Hashimoto's thyroiditis (hypothyroidism), symptoms can include weight changes, mood swings, heat or cold intolerance, and changes in heart rate.
- Type 1 diabetes mellitus symptoms: increased thirst and urination, weight loss, fatigue, and blurred vision.
Diagnosis[edit | edit source]
Diagnosis of APS-2 involves a combination of clinical evaluation and laboratory tests. Key diagnostic tests include:
- Autoantibody tests: to detect antibodies against the adrenal cortex, thyroid, and pancreatic islet cells.
- Hormone level tests: to assess the function of the affected glands (e.g., cortisol, thyroid hormones, and insulin).
- Imaging studies: such as ultrasound or CT scans, may be used to evaluate the structure of the thyroid gland and adrenal glands.
Treatment[edit | edit source]
Treatment of APS-2 focuses on managing the symptoms of the individual autoimmune diseases involved and may require a multidisciplinary approach. Common treatments include:
- Corticosteroids: for Addison's disease to replace the deficient hormones.
- Thyroid hormone replacement therapy: for Hashimoto's thyroiditis.
- Antithyroid drugs or radioactive iodine therapy: for Graves' disease.
- Insulin therapy: for type 1 diabetes mellitus.
Regular monitoring and adjustments of therapy are essential due to the progressive nature of these autoimmune diseases.
Prognosis[edit | edit source]
With appropriate treatment and monitoring, individuals with APS-2 can manage their symptoms and maintain a relatively normal quality of life. However, they must remain vigilant for the development of additional autoimmune diseases.
Epidemiology[edit | edit source]
APS-2 is less common than Autoimmune Polyendocrine Syndrome Type 1 (APS-1) but is more prevalent in certain populations, particularly those of Northern European descent. It typically presents in adulthood, with a higher incidence in females.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD